293 related articles for article (PubMed ID: 8996430)
1. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
Cambau E; Perani E; Guillemin I; Jamet P; Ji B
Lancet; 1997 Jan; 349(9045):103-4. PubMed ID: 8996430
[No Abstract] [Full Text] [Related]
2. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
3. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
Guerrero MI; Colorado CL; Torres JF; León CI
Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
[TBL] [Abstract][Full Text] [Related]
4. [Multi-drug resistant Mycobacterium leprae from patients with leprosy].
Maeda S
Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):227-33. PubMed ID: 15508725
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistant Mycobacterium leprae from patients with leprosy.
Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
[TBL] [Abstract][Full Text] [Related]
6. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
[TBL] [Abstract][Full Text] [Related]
7. High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen.
Chhabra S; Narang T; Sahu S; Sharma K; Shilpa S; Sharma A; Jain S; Singh I; Yadav R; Kaur M; Sharma R; Nadeem M; Pandey P; Minz RW; Dogra S
J Glob Antimicrob Resist; 2023 Dec; 35():262-267. PubMed ID: 37852372
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
[TBL] [Abstract][Full Text] [Related]
9. Lepromatous leprosy of histoid type.
Annigeri SR; Metgud SC; Patil JR
Indian J Med Microbiol; 2007 Jan; 25(1):70-1. PubMed ID: 17377360
[TBL] [Abstract][Full Text] [Related]
10. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
11. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
Dhople AM; Lamoureux LC; Gardner GD
Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
[TBL] [Abstract][Full Text] [Related]
12. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
Lopez-Roa RI; Fafutis-Morris M; Masanori M
Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
Dhople AM; Dimova V
Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
[TBL] [Abstract][Full Text] [Related]
14. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
Gupta UD; Katoch K; Katoch VM
Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
[TBL] [Abstract][Full Text] [Related]
15. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
[TBL] [Abstract][Full Text] [Related]
17. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
Lavania M; Singh I; Turankar RP; Ahuja M; Pathak V; Sengupta U; Das L; Kumar A; Darlong J; Nathan R; Maseey A
J Glob Antimicrob Resist; 2018 Mar; 12():214-219. PubMed ID: 29097343
[TBL] [Abstract][Full Text] [Related]
18. Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases.
Ahuja M; Singh I; Lavania M; Pathak VK; Darlong J; Turankar RP; Hembrom S; Singh SV; Sengupta U
J Glob Antimicrob Resist; 2022 Sep; 30():282-285. PubMed ID: 35717020
[TBL] [Abstract][Full Text] [Related]
19. Concepts behind the development of multiple drug therapy regimens in leprosy.
Waters MF
Lepr Rev; 1986 Dec; 57 Suppl 1():61-7. PubMed ID: 3295437
[No Abstract] [Full Text] [Related]
20. [DNA microarray based rapid drug susceptibility test for Mycobacterium leprae].
Suzuki Y; Matsuoka M
Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):271-7. PubMed ID: 17037383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
